Investments
3Portfolio Exits
1
Want to inform investors similar to Richmont Capital Partners about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Richmont Capital Partners Investments
3 Investments
Richmont Capital Partners has made 3 investments. Their latest investment was in GX Pharma as part of their Series B - II on December 12, 2022.

Richmont Capital Partners Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
12/13/2022 | Series B - II | GX Pharma | $14.39M | Yes | 1 | |
4/24/2001 | Unattributed VC | |||||
3/21/2000 | Series A |
Date | 12/13/2022 | 4/24/2001 | 3/21/2000 |
---|---|---|---|
Round | Series B - II | Unattributed VC | Series A |
Company | GX Pharma | ||
Amount | $14.39M | ||
New? | Yes | ||
Co-Investors | |||
Sources | 1 |
Richmont Capital Partners Portfolio Exits
1 Portfolio Exit
Richmont Capital Partners has 1 portfolio exit. Their latest portfolio exit was Attenza on March 24, 2003.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
3/24/2003 | Acquired |
Date | 3/24/2003 |
---|---|
Exit | Acquired |
Companies | |
Valuation | |
Acquirer | |
Sources |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.